PL2192896T3 - Pochodne karbonyloaminowe użyteczne do leczenia choroby zapalnej jelit - Google Patents
Pochodne karbonyloaminowe użyteczne do leczenia choroby zapalnej jelitInfo
- Publication number
- PL2192896T3 PL2192896T3 PL08787357T PL08787357T PL2192896T3 PL 2192896 T3 PL2192896 T3 PL 2192896T3 PL 08787357 T PL08787357 T PL 08787357T PL 08787357 T PL08787357 T PL 08787357T PL 2192896 T3 PL2192896 T3 PL 2192896T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- inflammatory bowel
- bowel disease
- derivatives useful
- carbonylamino derivatives
- Prior art date
Links
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 title abstract 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95781107P | 2007-08-24 | 2007-08-24 | |
| DKPA200701211 | 2007-08-24 | ||
| EP08787357A EP2192896B1 (en) | 2007-08-24 | 2008-08-21 | Carbonylamino derivatives useful for the treatment of inflammatory bowel disease |
| PCT/EP2008/060910 WO2009027292A1 (en) | 2007-08-24 | 2008-08-21 | Carbonylamino derivatives useful for the treatment of certain inflammatory disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2192896T3 true PL2192896T3 (pl) | 2011-06-30 |
Family
ID=39870538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08787357T PL2192896T3 (pl) | 2007-08-24 | 2008-08-21 | Pochodne karbonyloaminowe użyteczne do leczenia choroby zapalnej jelit |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8455549B2 (pl) |
| EP (2) | EP2322164A3 (pl) |
| JP (1) | JP2010536827A (pl) |
| AT (1) | ATE494891T1 (pl) |
| DE (1) | DE602008004563D1 (pl) |
| DK (1) | DK2192896T3 (pl) |
| ES (1) | ES2358564T3 (pl) |
| HR (1) | HRP20110189T1 (pl) |
| PL (1) | PL2192896T3 (pl) |
| PT (1) | PT2192896E (pl) |
| WO (1) | WO2009027292A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2742610A1 (en) | 2008-11-10 | 2010-05-14 | Jun Li | Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels |
| US10179115B2 (en) | 2015-02-20 | 2019-01-15 | The Children's Medical Center Corporation | Methods for treating malaria using potassium channel inhibitors |
| CA3076520A1 (en) * | 2016-10-25 | 2018-05-03 | Paracelsus Neuroscience I, LLC | Use of senicapoc for treatment of neuropathic pain |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997034589A1 (en) | 1996-03-20 | 1997-09-25 | President And Fellows Of Harvard College | Triaryl methane compounds for sickle cell disease |
| US5889038A (en) | 1996-03-20 | 1999-03-30 | Children's Hospital | Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds |
| US6288122B1 (en) | 1999-02-23 | 2001-09-11 | Icagen, Inc. | Gardos channel antagonists |
| US6548522B1 (en) | 1999-10-12 | 2003-04-15 | Hoffmann-La Roche Inc. | Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives |
| US6803375B1 (en) | 2000-01-06 | 2004-10-12 | The Regents Of The University Of California | Non-peptide inhibition of T-lymphocyte activation and therapies related thereto |
| WO2003004010A1 (en) * | 2001-07-06 | 2003-01-16 | Poseidon Pharmaceuticals A/S | Carbonylamino derivatives useful for obtaining immune regulation |
| DE60322019D1 (de) | 2002-01-04 | 2008-08-21 | Neurosearch As | Kaliumkanal-modulatoren |
| US7129618B2 (en) * | 2003-03-31 | 2006-10-31 | Canon Kabushiki Kaisha | Control apparatus capable of low-speed driving of vibration type driving apparatus, actuating apparatus using the control apparatus, control method capable of low-speed driving of vibration type driving apparatus, and storage medium storing program including program codes capable of realizing the control method |
| GB0414272D0 (en) | 2004-06-25 | 2004-07-28 | Cellpep Sa | OsK1 derivatives |
| WO2007075849A2 (en) * | 2005-12-20 | 2007-07-05 | Icagen, Inc. | Treatment methods using triaryl methane compounds |
-
2008
- 2008-08-21 WO PCT/EP2008/060910 patent/WO2009027292A1/en not_active Ceased
- 2008-08-21 EP EP10187737A patent/EP2322164A3/en not_active Withdrawn
- 2008-08-21 PL PL08787357T patent/PL2192896T3/pl unknown
- 2008-08-21 AT AT08787357T patent/ATE494891T1/de active
- 2008-08-21 PT PT08787357T patent/PT2192896E/pt unknown
- 2008-08-21 ES ES08787357T patent/ES2358564T3/es active Active
- 2008-08-21 DE DE602008004563T patent/DE602008004563D1/de active Active
- 2008-08-21 DK DK08787357.6T patent/DK2192896T3/da active
- 2008-08-21 JP JP2010521421A patent/JP2010536827A/ja active Pending
- 2008-08-21 EP EP08787357A patent/EP2192896B1/en not_active Not-in-force
- 2008-08-21 HR HR20110189T patent/HRP20110189T1/hr unknown
- 2008-08-21 US US12/674,746 patent/US8455549B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20110189T1 (hr) | 2011-04-30 |
| US20110124735A1 (en) | 2011-05-26 |
| JP2010536827A (ja) | 2010-12-02 |
| EP2322164A3 (en) | 2011-12-07 |
| WO2009027292A1 (en) | 2009-03-05 |
| EP2192896B1 (en) | 2011-01-12 |
| EP2192896A1 (en) | 2010-06-09 |
| ES2358564T3 (es) | 2011-05-11 |
| US8455549B2 (en) | 2013-06-04 |
| ATE494891T1 (de) | 2011-01-15 |
| DE602008004563D1 (de) | 2011-02-24 |
| PT2192896E (pt) | 2011-04-04 |
| EP2322164A2 (en) | 2011-05-18 |
| DK2192896T3 (da) | 2011-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011069063A3 (en) | Multicyclic compounds and methods of use thereof | |
| ZA200806074B (en) | Compounds for the treatment of inflammatory disorders | |
| IL194076A0 (en) | Imidazolothiazole compounds for the treatment of disease | |
| IL186749A0 (en) | Dihydrothienopyrimidines for the treatment of inflammatory diseases | |
| PL2049132T3 (pl) | Nowe środki do leczenia zaburzeń związanych z osłabionym neuroprzekaźnictwem | |
| PL2318035T3 (pl) | Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego | |
| PL2021006T3 (pl) | Zastosowanie flibanseryny do leczenia pomenopauzalnych zaburzeń popędu płciowego | |
| LTPA2019504I1 (lt) | Pagerintos TM nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui | |
| LT2229369T (lt) | 6,7-dialkoksi-chinazolino dariniai, tinkami panaudoti su vėžiu susijusių susirgimų gydymui | |
| ZA200806455B (en) | Use of 2-imidazoles for the treatment of CNS disorders | |
| IL192877A0 (en) | Use of 2-imidazoles for the treatment of cns disorders | |
| ATE494891T1 (de) | Carbonylamino-derivate zur behandlung von entzündlicher darmerkrankung | |
| EP2099444A4 (en) | USE OF D-SERIN DERIVATIVES FOR THE TREATMENT OF ANTIBODIES | |
| ZA201104663B (en) | Sulfonamide compounds for the treatment of respiratory disorders | |
| EP2387565A4 (en) | 2,4-PYRIMIDINDIAMIN COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| IL198432A0 (en) | 2-alkyl-indazole compounds for the treatment of certain cns-related disorders | |
| PL2036575T3 (pl) | Kompozycje farmaceutyczne do stosowania doustnie w leczeniu pacjentów dotkniętych otyłością | |
| EP2212246B1 (en) | TREATMENT OF NEUROLOGICAL DISORDER | |
| GB0604780D0 (en) | Use of substituted piperazine compounds for the treatment of food related disorders | |
| GB0604781D0 (en) | Use of substituted phenyl-piperazine compounds for the treatment of food related disorders | |
| GB0604782D0 (en) | Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders | |
| GB0604772D0 (en) | Use of substituted amine compounds for the treatment of food related disorders | |
| GB0715256D0 (en) | Benzylthiazolypiperazine derivatives for the treatment of neuro degenerative diseases | |
| IL194261A0 (en) | S-alkylisothiouronium derivatives for the treatment of inflammatory diseases | |
| GB0715253D0 (en) | Aromatic derivatives for the treatment of neuro degenerative diseases |